Gerard Silvestri to Diagnosis, Differential
This is a "connection" page, showing publications Gerard Silvestri has written about Diagnosis, Differential.
Connection Strength
0.474
-
Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2021 03; 159(3):1283-1287.
Score: 0.141
-
Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2018 09; 154(3):491-500.
Score: 0.117
-
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest. 2014 Mar 01; 145(3):464-472.
Score: 0.089
-
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):178S-201S.
Score: 0.057
-
Factors that influence physician decision making for indeterminate pulmonary nodules. Ann Am Thorac Soc. 2014 Dec; 11(10):1586-91.
Score: 0.023
-
Tissue verification of stage I sarcoidosis: the question is if, not how. Chest. 2008 Jun; 133(6):1529-1530.
Score: 0.015
-
A 69-year-old with lung mass and mediastinal lymphadenopathy on chest computed tomography. Clin Gastroenterol Hepatol. 2007 Aug; 5(8):908-11.
Score: 0.014
-
Unusual presentations of pulmonary sarcoidosis: cases from the medical university of South Carolina. Semin Respir Crit Care Med. 2007 Feb; 28(1):75-82.
Score: 0.014
-
Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome. Clin Pharmacol Ther. 1991 Nov; 50(5 Pt 1):580-6.
Score: 0.005